Circadian disruption affects the pathogenesis and development of various diseases. Depression is one of the most common diseases that relate to circadian rhythm. In this study, we analyzed the effects of daily light/dark (LD) conditions on depression and other symptoms, and also analyzed the mixed effects of LD conditions and corticosterone treatment. Male adult C57BL/6 mice were treated with corticosterone in a normal LD cycle of 12 hours light and 12 hours dark (LD12 : 12), short day conditions of 6 hours light and 18 hours dark (LD6 : 18), or long day conditions of 21 hours light and 3 hours dark (LD21 : 3). The activity rhythms of mice in aberrant LD conditions were entrained within 2 weeks. After 6 weeks of exposure, several behavioral tests were conducted. Corticosterone induced body weight gain and depression-like symptoms. The short or long LD conditions had little effect on vehicle-treated mice behavior. However, the aberrant LD conditions exacerbated the corticosterone-induced symptoms. Mice treated with corticosterone in LD6 : 18 showed exacerbated depression-like symptoms in a novelty suppressed feeding test. On the other hand, LD21 : 3 did not show any effects on mood, but enhanced corticosterone-induced body weight gain. These results indicated that aberrant LD conditions could act as an exacerbating factor for corticosterone-induced symptoms, and that short and long photoperiods induce different psychological and physiological changes. This corticosterone + aberrant LD model could be a useful animal model for investigating the effect of LD conditions on depression, obesity, and other symptoms in stressful circumstances.
Circadian rhythm governs almost all mammalian organs. Impairment of circadian rhythm causes dysfunction of physiological systems, which sometimes affects the pathogenesis and development of various diseases. Depression is one of the most common diseases that relate to circadian rhythms. In this study, we analyzed the effects of daily light/dark (LD) conditions on the symptoms induced by corticosterone. Chronic corticosterone treatment induces depression-like symptom, and is widely used to develop and analyze depression in rodents. Male adult C57BL/6N mice were maintained in a normal light/dark (LD) cycle of 12 hours light and 12 hours dark (LD12:12), short day conditions of 6 hours light and 18 hours dark (LD6:18), or long day conditions of 21 hours light and 3 hours dark (LD21:3). Mice were exposed to 35 mg/L of corticosterone or vehicle in the drinking water. Mice were divided into 4 groups: control, corticosterone, aberrant LD (LD6:18 or LD21:3), and corticosterone + aberrant LD. After 6 weeks of exposure, open field test, LD box test, tail suspension test, and novelty suppressed feeding test were conducted to detect depression-and anxiety-like symptoms. Corticosterone treatment induced body weight gain and depression/anxiety-like symptoms. Although the short or long photoperiod alone induced little changes, the aberrant LD exacerbated the corticosterone-induced symptoms. Mice with corticosterone+LD6:18 showed larger changes in novelty suppressed feeding test than mice with corticosterone. Short photoperiod seemed to worsen corticosterone-induced depression. On the other hand, the long photoperiod showed no obvious effects on mood. However, mice with corticosterone+LD21:3 showed larger weight gain than mice with corticosterone. Long photoperiod seemed to enhance corticosterone-induced weight gain. These results indicated that aberrant LD could act as an exacerbating factor for corticosterone-induced symptoms, and that long and short photoperiod have different physiological effects on mood and weight control. Since people are usually exposed to various stresses and risk factors, aberrant LD cycle might have a large impact on their health. Mice with corticosterone + aberrant LD might be a useful animal model for investigating the effects of LD conditions on depression, obesity, and other symptoms in such stressful circumstances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.